Edward C English's Net Worth

$5.76 Million

Estimate Recalculated Sep 8, 2024 07:30PM EST

Who is Edward C English?

Edward C English has an estimated net worth of $5.76 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., Xilio Therapeutics, Inc., AMAG PHARMACEUTICALS INC., and PRAECIS PHARMACEUTICALS INC.

SEC CIK

Edward C English's CIK is 0001302600

Past Insider Trading and Trends

2016 was Edward C English's most active year for acquiring shares with 10 total transactions. Edward C English's most active month to acquire stocks was the month of February. 2016 was Edward C English's most active year for disposing of shares, totalling 17 transactions. Edward C English's most active month to dispose stocks was the month of May. 2017 saw Edward C English paying a total of $945,883.16 for 33,887 shares, this is the most they've acquired in one year. In 2017 Edward C English cashed out on 59,578 shares for a total of $4,465,250.71, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TESARO, Inc. No price found

VP Finance & Administration

Edward C English owns 396 units of Common Stock, par value $0.0001, 396 units of Common Stock, par value $.0001, 396 units of Common Stock. Edward C English used to own units in Common Stock, par value $.01 but no longer holds any shares there. From 2012 to 2014 Edward C English acquired a total of 77,987 shares in TESARO, Inc. at a cost of $2,066,328.16, Edward also disposed a total of 77,591 shares of TESARO, Inc. equalling to $7,819,939.21.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$86.67
-$1,048,165.04
396
Scheduled
Sep 6
Form 4
—
0
$83.39
-$939,529.82
396
Scheduled
Jun 6
Form 4
—
0
$103.51
-$1,491,000.00
396
Scheduled
Mar 6
Form 4
∞
396
$177.61
-$40,672.69
396
Scheduled
Mar 1 - Mar 2
Form 4
—
0
$79.22
-$996,670.00
0
Scheduled
Dec 12
Form 4
—
0
$56.04
-$455,128.00
0
Scheduled
Sep 8
Form 4
—
0
$32.14
-$120,599.00
0
Scheduled
Jun 10
Form 4
—
0
$33.62
-$141,270.00
0
Scheduled
Mar 10
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
$34.88
-$520,576.50
0
Scheduled
Dec 10
Form 4
—
0
—
—
0
Mar 6
Form 4
—
0
—
—
0
May 8
Form 4/A
—
0
—
—
0
Feb 27
Form 4
—
0
—
—
0
Feb 27
Form 4
—
0
—
—
0
Aug 30
Form 4
—
0
—
—
0
Mar 6
Form 3
—
0
—
—
0
No matching records found

Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844

PRINCIPAL ACCOUNTING OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 1
Form 3
—
0
—
—
0
No matching records found

AMAG PHARMACEUTICALS INC. No price found

VP, Controller, Interim CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

PRAECIS PHARMACEUTICALS INC No price found

VP, CFO, Treasurer & Ass. Sec.

Edward C English used to own units in Common Stock, par value $.01 per share but no longer holds any shares there. In the year 2004 Edward C English filed a total of 5 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.96K
$5.00
-$9,780.00
0
Feb 7
Form 4
—
0
—
—
0
May 27
Form 4
—
0
—
—
0
Nov 11
Form 4
—
0
—
—
0
Sep 16
Form 3
—
0
—
—
0
No matching records found